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The avian-adapted serovar Salmonella
Gallinarum, which includes two biovars,
Gallinarum and Pullorum, was endemic in
poultry flocks in Europe and the Americas in the
early 20th century (1). To reduce economic losses
to the poultry industry, national surveillance
programs were established in the United States
(National Poultry Improvement Plan, 1935) and
England and Wales (Poultry Stock Improvement
Plan, 1939). Since S. Gallinarum (antigen
formula O9,12:-:-) has no animal reservoir other
than domestic and aquatic fowl, the test-and-
slaughter method of disease control under these
surveillance programs led to its eradication from
commercial poultry flocks in the United States,
England, and Wales by the 1970s (1,2). At that
time, the number of human cases of infection
with serovar S. Enteritidis (antigen formula
O9,12:g,m:1,7) began to increase in these
countries (3,4). By the 1980s, S. Enteritidis had
emerged as a major concern for food safety in
Europe and the Americas (5); by 1990 it was the
most frequently reported Salmonella serovar in
the United States (6). Most S. Enteritidis
outbreaks in Europe and the United States are
associated with foods containing undercooked
eggs (7-10). Eggs can become contaminated with
S. Enteritidis through cracks in the shell after
contact with chicken feces or by transovarian
infection (11). Thus, laying hens were the likely
source of the S. Enteritidis epidemic in Europe
and the Americas.
The inverse relationship between the inci-
dence of S. Gallinarum infection in chickens and
egg-associated  S. Enteritidis infections in
humans prompted the hypothesis that
S. Enteritidis filled the ecologic niche vacated by
eradication of S. Gallinarum from domestic fowl
(12). The hypothesis suggests that the epidemic
increase in human S. Enteritidis cases in several
geographic areas can be traced to the same origin,
accounting for the simultaneous emergence of
S. Enteritidis as a major egg-associated pathogen
on three continents (5). A connection between the
epidemics in Western Europe and the United
States was not apparent from analysis of
epidemic isolates. Although most human cases
from England and Wales result from infection
with S. Enteritidis phage type 4 (PT4), most cases
in the United States are due to infections with
PT8 and PT13a (13,14). The PT4 clone is
genetically distinct from PT8 and 13a, as shown
Competitive Exclusion of
Salmonella Enteritidis by
Salmonella Gallinarum in Poultry
Wolfgang Rabsch,* Billy M. Hargis,† Renée M. Tsolis,†
Robert A. Kingsley,† Karl-Heinz Hinz,‡
Helmut Tschäpe,* and Andreas J. Bäumler†
*Robert Koch Institute, Wernigerode, Germany; †Texas A&M University,
College Station, Texas, USA; ‡School of Veterinary Medicine,
Hanover, Germany
Salmonella Enteritidis emerged as a major egg-associated pathogen in the late
20th century. Epidemiologic data from England, Wales, and the United States indicate
that S. Enteritidis filled the ecologic niche vacated by eradication of S. Gallinarum from
poultry, leading to an epidemic increase in human infections. We tested this hypothesis
by retrospective analysis of epidemiologic surveys in Germany and demonstrated that
the number of human S. Enteritidis cases is inversely related to the prevalence of S.
Gallinarum in poultry. Mathematical models combining epidemiology with population
biology suggest that S. Gallinarum competitively excluded S. Enteritidis from poultry
flocks early in the 20th century.444 Emerging Infectious Diseases Vol. 6, No. 5, September–October 2000
Perspective
Figure. (A) S. Gallinarum infections in chickens in
England and Wales (closed squares) (2,27) and the
Federal Republic of Germany (open squares) (28). (B)
Human cases of S. Enteritidis infections per year
reported from England and Wales (closed circles)
(3,29) and the Federal Republic of Germany (open
circles) (Zentrales Überwachungsprogram Salmo-
nella, ZÜPSALM).
by IS200 profiling, ribotyping, and restriction
fragment length polymorphism of genomic DNA
fragments separated by pulsed-field gel electro-
phoresis (15). The reasons for the differing clonal
isolates in the United States and Western Europe
are unknown. S. Enteritidis was likely introduced
into poultry flocks from its rodent reservoir (12).
The geographic differences in predominant
phage types may reflect the fact that at the time
of introduction into poultry flocks, different
S. Enteritidis strains were endemic in rodent
populations in Europe and the United States.
Subsequently,  S. Enteritidis strains with the
highest transmissibility may have become
predominant in poultry flocks on each continent.
An alternative explanation for the predominance
of PT4 in England and Wales is its introduction
into poultry breeding lines in the early 1980s (16),
which may have accelerated the epidemic spread
of PT4 in laying hens and resulted in its
dominance in human isolates from England and
Wales. However, factors responsible for the
beginning of the S. Enteritidis epidemic should
be considered separately from those important
for its subsequent spread within the poultry
industry. These factors were not specific to PT4
but rather allowed different phage types to
emerge as egg-associated pathogens on different
continents at the same time (5).
One such factor could be the eradication of
S. Gallinarum from poultry, which would
facilitate circulation of S. Enteritidis strains
within this animal reservoir regardless of phage
type. Experimental evidence indicates that
immunization with one Salmonella serovar can
generate cross-immunity against a second serovar
if both organisms have the same immunodomi-
nant O-antigen on their cell surface (17-19). The
immunodominant epitope of the lipopolysaccha-
ride of S. Gallinarum and S. Enteritidis is the O9-
antigen, a tyvelose residue of the O-antigen
repeat (20). Immunization of chickens with
S. Gallinarum protects against colonization with
S. Enteritidis (21,22) but not S. Typhimurium, a
serovar expressing a different immunodominant
determinant, the O4-antigen (23). Theory
indicates that coexistence of S. Gallinarum and
S. Enteritidis in an animal population prompts
competition as a result of the shared immuno-
dominant O9-antigen, which generates cross-
immunity. Mathematical models predict that the
most likely outcome of this competition between
serovars is that the serovar with the higher
transmission success will competitively exclude
the other from the host population (24-26).
S. Gallinarum may have generated population-
wide immunity (flock immunity) against the O9-
antigen at the beginning of the 20th century,
thereby excluding S. Enteritidis strains from
circulation in poultry flocks (12). This proposal is
based on analysis of epidemiologic data from the
United States, England, and Wales. To formally
test this hypothesis, we analyzed epidemiologic
data from Germany to determine whether the
numbers of human S. Enteritidis cases are
inversely related to those of S. Gallinarum cases
reported in poultry. We used mathematical
models to determine whether our hypothesis is
consistent with theoretical considerations re-
garding transmissibility and flock immunity.
Inverse Relationship of S. Enteritidis
and S. Gallinarum Isolations in Germany
In West Germany, the number of human
S. Enteritidis cases was monitored by a national
surveillance program (Figure) (Zentrales
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from 1973 to 1982. In 1975, the number of human
infections began to increase, indicating the
beginning of the S. Enteritidis epidemic in West
Germany. In 1983 the ZÜPSALM program was
replaced by a national program for surveillance of
foodborne disease outbreaks (Zentrale Erfassung
von Ausbrüchen lebensmittelbedingter Infek-
tionen, ZEVALI), implemented by the Depart-
ment of Public Health (Bundesgesundheitsamt).
In the first year of this program, S. Enteritidis
was responsible for 62 outbreaks, most of which
were traced to raw eggs. By 1988, the number of
disease outbreaks caused by S. Enteritidis had
increased to 1,365.
In 1967 in England and Wales, poultry,
particularly chickens, became the main human
food source of S. Enteritidis (3). Before that date,
the organism had only sporadically been isolated
from poultry (3). A continuous increase in human
S. Enteritidis cases was recorded from 1968 until
the epidemic peaked in 1994 (12,16). Thus, the
human S. Enteritidis epidemic in England and
Wales probably began in 1968 after this organism
became associated with a human food source,
chickens. The rapid increase in the number of
human cases from 1982 to 1988 was probably due
to the introduction of PT4 into poultry breeding
lines in England and Wales (16). Comparison of
data from England and Wales (3,29) showed that
S. Enteritidis emerged somewhat later in West
Germany (Figure).
Eradication of S. Gallinarum was among the
factors contributing to the emergence of
S. Enteritidis as a foodborne pathogen (12). To
determine whether delayed elimination of avian-
adapted  Salmonella serovars from commercial
flocks contributed to the late start of the human
epidemic in Germany, we compared the results of
surveys performed in poultry flocks in Germany
with those from the United Kingdom and the
United States. Control programs in the 1930s
triggered a steady decline in the incidence of
S. Gallinarum in poultry flocks in the United
States, England, and Wales (1,2,12). By the early
70s, only a few cases of S. Gallinarum were
reported each year to veterinary investigation
centers in England and Wales (27). In Germany,
the first national survey performed by the
Department of Public Health (Reichsgesundheit-
samt) in 1929 showed that 16.3% of birds were
seropositive for S. Gallinarum (30). Blood-testing
performed 20 years later with 6,313 birds in a
province (Südbaden) of West Germany still
detected 19.5% reactors (31). This high preva-
lence of S. Gallinarum in 1949 likely reflects the
fact that after World War II available resources
were directed toward rebuilding the poultry
industry rather than improving disease control.
The comparatively slow decline in the prevalence
of S. Gallinarum in West Germany is illustrated
further by data for cases of disease reported from
poultry. The number of S. Gallinarum isolations
from chicken carcasses received by veterinary
laboratories in West Germany was reported by a
surveillance program from 1963 to 1981 (28).
During this period, the rate of decrease in
numbers of S. Gallinarum cases in England and
Wales was considerably higher than that
reported from West Germany (Figure). In each
country the numbers of S. Gallinarum cases were
inversely related to the numbers of human
S. Enteritidis cases. These data are consistent
with the concept that the relative delay in
eradicating S. Gallinarum from poultry may have
contributed to delayed onset of the S. Enteritidis
epidemic in West Germany.
Competitive exclusion of
S. Enteritidis by S. Gallinarum
To calculate whether the prevalence of S.
Gallinarum in chickens was high enough to
generate flock immunity against S. Enteritidis,
we analyzed epidemiologic data by mathematical
models combining epidemiology with population
biology (24-26). The transmission success of a
pathogen is measured by the basic case-
reproductive number, R0, which is defined as the
average number of secondary cases of infection
from a primary case in a susceptible host
population (32). In direct transmission, the basic
case-reproductive number of a pathogen is
directly proportional to the duration, D, for which
an infected host can transmit the disease before it
is either killed or clear of infection; the
probability, ß, by which the disease is transmit-
ted from an infected animal to a susceptible host;
and the density of susceptible hosts, X (24).
R0=ßDX (equation 1)
After a pathogen is introduced into a
susceptible host population, the reproductive
rate of the infection declines as a consequence of
the removal of a fraction, y, of the susceptible
population, X, either by disease-induced death or446 Emerging Infectious Diseases Vol. 6, No. 5, September–October 2000
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acquisition of immunity. That is, the effective
case-reproductive number, R, will be smaller
than the basic case-reproductive number R0.
R = ßD (X-Xy) = R0-R0y (equation 2)
In an endemic state, each primary case of
infection produces, on average, one secondary
case. Thus, the effective case-reproductive
number in a steady endemic-state situation is
R=1. By solving equation 2 for R0, we obtain (33)
R0=1/(1-y) (equation 3)
Since S. Gallinarum was endemic in poultry
populations at the beginning of the 20th century,
its basic case-reproductive number, R0, can be
calculated on the basis of epidemiologic data
collected before control measures were imple-
mented, by estimating the fraction, y, of birds
removed from the susceptible population.
The first method developed for detecting
anti-S. Gallinarum antibodies was a macroscopic
tube agglutination test introduced in 1913 (34).
In 1931, the tube agglutination test was partially
replaced by the simpler whole-blood test for slide
agglutination of stained antigen (35). Initial
surveys performed from 1914 to 1929 revealed
that on average 9.8% to 23.8% of poultry in
Europe and the United States were positive by
the tube agglutination test (1,30,36). These data
do not provide a direct estimate of the number of
immune animals, since both serologic tests are
relatively insensitive (37). However, the number
of susceptible birds can be estimated by
comparing results of serologic surveys with data
from vaccination experiments. Immunization
with S. Gallinarum vaccine strain 9R produces
antibody levels high enough to be detected by the
whole-blood tube or slide agglutination tests in
only a small number of birds (approximately
10%) (20,23). The number of birds protected
against challenge with virulent S. Gallinarum
after a single oral or subcutaneous vaccination is
considerably higher (approximately 60%) (23,38).
The tube or slide agglutination test results (9.8%
and 23.8% of birds, respectively, tested positive)
at the beginning of this century suggest that at
least 60% were immune to S. Gallinarum. In
addition to acquired immunity, deaths, which
likely occurred in most chicken flocks since
S. Gallinarum reactors were present on most
farms at the time, also reduced the density of
susceptible hosts. For instance, only 9 of 144
farms surveyed in Hungary in the 1930s had no
S. Gallinarum-positive birds (39). The death rates
reported from natural outbreaks are 10% to 50%,
although higher rates are occasionally reported
(40). By the conservative estimate that 90% of
birds in a flock will survive an outbreak and
approximately 60% of the survivors will have
protective immunity, the basic case-reproductive
number, R0, of S. Gallinarum is estimated to be 2.8.
S. Enteritidis does not substantially reduce
the density of susceptible animals by causing
death. Thus, its basic case-reproductive number
can be estimated from the number of birds that
remained susceptible during the peak of the
S. Enteritidis epidemic. Antibody titers in
S. Enteritidis-infected flocks are generally too
low to be detected by the tube or the slide
agglutination tests (37,41), presumably because
this serovar commonly colonizes birds without
causing disease and consequently without trigger-
ing a marked immune response. Live attenuat-
ed S. Enteritidis aroA vaccine does not produce
antibody titers detectable by the tube or the slide
agglutination tests (42), and  oral immunization
with this vaccine does not protect against organ
colonization with wild-type S. Enteritidis (43).
Hence, exposure to S. Enteritidis does not protect
at levels found in birds with previous exposure to
S. Gallinarum. Indeed, in a survey of flocks
naturally infected with S. Enteritidis, only one of
114 birds tested strongly positive by the slide
agglutination test (37). Experimental evidence
indicates that birds exposed to S. Gallinarum
have strong cross-immunity against colonization
with S. Enteritidis. For instance, immunization
of chickens with a single dose of S. Gallinarum
vaccine strain 9R causes similar levels of
protection against challenge with S. Gallinarum
(23,38) and S. Enteritidis (22,44). The high
degree of cross-immunity suggests that the
antibody titers detected by the tube agglutination
test are predictive of protection against lethal
S. Gallinarum infection and of immunity to
colonization by S. Enteritidis. Applying the
criteria used to calculate R0 for S. Gallinarum
(10% reactors are indicative of 60% protection) to
the  S. Enteritidis data (37) suggests that
approximately 5% of birds had protective
immunity against this pathogen. From these
data, the basic case-reproductive number of
S. Enteritidis (R0=1.05) is estimated to be
considerably lower than that of S. Gallinarum.Vol. 6, No. 5, September–October 2000 Emerging Infectious Diseases 447
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Several factors should be considered in
interpreting these data. Our estimate of the R0
value for S. Enteritidis is based on epidemiologic
data from the late 1980s. The intensive
husbandry of chickens in the latter part of the
20th century has increased the density, X, of
susceptible hosts and therefore R0 (equation 1).
Furthermore, information on the number of birds
in  S. Enteritidis-infected flocks with positive
reactions in the tube agglutination test is sparse,
and data from the peak of the epidemic in 1994
are not available. The prevalence of S. Enteritidis
in poultry has been documented by a survey
performed in Lower Saxony, Germany, in 1993, a
time when flocks were heavily infected. This
study showed that 7.6% of 2,112 laying hens were
culture positive at slaughter (45). Although this
low prevalence is consistent with a low basic case-
reproductive number of S. Enteritidis at the peak
of the epidemic, these data cannot be used to
derive a reliable estimate for the basic case-
reproductive number of S. Enteritidis at the
beginning of the 20th century. Given these
limitations, the available epidemiologic evidence
appears to be consistent with our hypothesis.
From equation 2 (R=R0-R0y), we estimate that
early in the century the number of susceptible
birds killed by S. Gallinarum (assuming 100%
cross-immunity and y = 0.65) reduced the
effective case-reproductive number of S. Enteriti-
dis to < 1 (R = 0.37). These estimates support the
idea that at the beginning of the 20th century
S. Gallinarum reduced the density of susceptible
hosts sufficiently to competitively exclude S.
Enteritidis from circulation in poultry flocks.
S. Enteritidis is unlikely to be eliminated
from poultry by relying solely on the test-and-
slaughter method of disease control because,
unlike  S. Gallinarum, S. Enteritidis can be
reintroduced into flocks from its rodent reservoir.
Instead, vaccination would be effective in
excluding  S. Enteritidis from domestic fowl
because it would eliminate one of the risk factors
(loss of flock immunity against the O9-antigen),
which likely contributed to the emergence of
S. Enteritidis as a foodborne pathogen. In fact,
much of the decline in human S. Enteritidis cases
in England and Wales since 1994 has been
attributed to the use of an S. Enteritidis vaccine
in poultry (16). However, serologic evidence that
S. Gallinarum is more immunogenic than
S. Enteritidis suggests that a more effective
approach for eliciting protection in chickens
would be immunization with a live attenuated S.
Gallinarum vaccine. This approach would restore
the natural balance (exclusion of S. Enteritidis by
a natural competitor) that existed before human
intervention strategies were implemented early
in the 20th century.
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